EQ
Equillium, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-34/100
Last price
1.40
▼ 0.02 (1.41%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.41
Prev close
1.42
Day high
1.43
Day low
1.36
Volume
79.34K
Market cap
$88.77M
P/E (TTM)
—
52W range
0.76 – 3.54
Day trading desk
Gap from prior close
-0.70%
Prior close 1.42
VWAP
1.40
-0.31% from price
Relative volume
0.12×
Quiet session
Session range
4.78%
1.36 – 1.42
Position in range
62%
Mid range
ATR (14D)
0.13
9.06% of price
Prior day high
1.47
PDH
Prior day low
1.37
PDL
Bid / ask spread
—
Quote not published
Session volume
75.04K
Avg 621.82K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-14.11%
-15.6%
1M
-41.91%
-43.0%
3M
-52.70%
-55.7%
6M
-22.22%
-36.7%
YTD
-9.68%
-23.2%
1Y
-6.67%
-21.9%
3Y
+94.44%
+13.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EQ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-230.97K
Net selling
Buy transactions
3
175.42K shares
Sell transactions
4
406.39K shares
Net transactions
+7
Buys less sells
Sell : buy shares
2.3 : 1
Mixed
Insider-held shares
10.14M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 5, 26 | CONNELLY STEPHEN President |
SELL | 230.97K | $723.83K | Direct |
| Jun 5, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 14.58K | $42.74K | Direct |
| Jun 5, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
CONVERSION | 14.58K | $11.45K | Direct |
| May 28, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 95.83K | $267.21K | Direct |
| May 28, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
CONVERSION | 95.83K | $73.95K | Direct |
| May 28, 26 | TOM PENNY Officer |
SELL | 65.00K | $191.75K | Direct |
| May 28, 26 | TOM PENNY Officer |
CONVERSION | 65.00K | $51.02K | Direct |
| Mar 13, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 120.31K | $300.82K | Direct |
| Mar 13, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
CONVERSION | 120.31K | $94.44K | Direct |
| Mar 9, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 181.22K | $362.44K | Direct |
| Mar 9, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
CONVERSION | 152.36K | $119.60K | Direct |
| Feb 19, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 185.94K | $328.10K | Direct |
| Feb 19, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
CONVERSION | 185.94K | $141.75K | Direct |
| Feb 19, 26 | ZEDELMAYER CHRISTINE Chief Operating Officer |
SELL | 185.94K | $328.10K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CONNELLY STEPHEN |
President | 762.02K | Sale |
KEYES JASON A |
Chief Financial Officer | — | Sale |
TOM PENNY |
Officer | 0 | Sale |
ZEDELMAYER CHRISTINE |
Chief Operating Officer | 62.59K | Sale |
Fundamentals
Market cap$88.77M
Enterprise value$33.46M
Revenue (TTM)—
Gross profit—
EBITDA$-19.20M
Net income$-18.01M
EPS (TTM)$-0.14
Free cash flow$-14.30M
Total cash$57.16M
Total debt$584.00K
Book value / share$0.88
Shares outstanding63.41M
Float36.97M
Short % of float10.05%
Dividend yield0.00%
Beta (5Y)1.92
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.98
PEG ratio—
Price / sales—
Price / book1.59
EV / revenue—
EV / EBITDA-1.74
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-58.98%
Return on assets-33.95%
Debt / equity1.04
Current ratio23.40
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $41.09M | $36.08M | $15.76M | -100.0% |
| Operating revenue | $0 | $41.09M | $36.08M | $15.76M | -100.0% |
| Research & development | $12.84M | $37.43M | $37.04M | $37.55M | -65.7% |
| Selling, general & admin | $10.79M | $11.94M | $13.57M | $17.24M | -9.6% |
| Total operating expense | $23.63M | $49.36M | $50.61M | $54.79M | -52.1% |
| Operating income | -$23.63M | -$8.27M | -$14.52M | -$39.03M | -185.8% |
| Net interest income | $833.00K | $1.38M | $1.84M | -$633.00K | -39.7% |
| Pre-tax income | -$22.40M | -$7.71M | -$12.76M | -$62.43M | -190.7% |
| Tax provision | $0 | $361.00K | $580.00K | $0 | -100.0% |
| Net income | -$22.40M | -$8.07M | -$13.34M | -$62.43M | -177.6% |
| Net income to common | -$22.40M | -$8.07M | -$13.34M | -$62.43M | -177.6% |
| Basic EPS | -0.39 | -0.23 | -0.38 | -1.85 | -69.6% |
| Diluted EPS | -0.39 | -0.23 | -0.38 | -1.85 | -69.6% |
| EBIT | -$23.63M | -$8.27M | -$12.26M | -$61.38M | -185.8% |
| EBITDA | -$23.52M | -$8.13M | -$12.14M | -$61.26M | -189.2% |
| Basic shares | 57.30M | 35.36M | 34.73M | 33.73M | +62.1% |
| Diluted shares | 57.30M | 35.36M | 34.73M | 33.73M | +62.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.28M | $18.09M | $23.22M | $59.11M | — | +67.4% |
| Cash & short-term investments | $30.28M | $22.57M | $40.87M | $71.02M | — | +34.1% |
| Accounts receivable | — | $0 | $3.73M | $2.84M | $0 | — |
| Total current assets | $31.04M | $24.98M | $49.35M | $76.73M | — | +24.3% |
| Property, plant & equipment | $822.00K | $626.00K | $1.11M | $1.58M | — | +31.3% |
| Total assets | $31.89M | $25.60M | $50.53M | $78.42M | — | +24.5% |
| Total current liabilities | $2.93M | $6.36M | $27.57M | $32.04M | — | -53.8% |
| Current debt | — | — | — | $5.71M | $1.43M | — |
| Long-term debt | — | — | — | $3.24M | $8.75M | — |
| Total debt | $719.00K | $384.00K | $824.00K | $10.19M | — | +87.2% |
| Total liabilities | $3.29M | $6.54M | $27.96M | $46.48M | — | -49.7% |
| Retained earnings | -$216.21M | -$193.81M | -$185.74M | -$172.41M | — | -11.6% |
| Shareholder equity | $28.60M | $19.06M | $22.57M | $31.94M | — | +50.0% |
| Working capital | $28.10M | $18.62M | $21.78M | $44.70M | — | +50.9% |
| Net tangible assets | $28.60M | $19.06M | $22.57M | $31.94M | — | +50.0% |
| Shares issued | 61.46M | 35.56M | 35.25M | 34.41M | — | +72.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$22.40M | -$8.07M | -$13.34M | -$62.43M | -177.6% |
| Depreciation & amortisation | $116.00K | $137.00K | $126.00K | $118.00K | -15.3% |
| Stock-based compensation | $2.32M | $3.75M | $4.00M | $4.84M | -38.1% |
| Change in working capital | -$2.32M | $842.00K | -$2.55M | $19.00K | -375.2% |
| Operating cash flow | -$22.75M | -$19.03M | -$21.78M | -$8.73M | -19.6% |
| Capital expenditure | -$48.00K | -$85.00K | -$50.00K | -$279.00K | +43.5% |
| Investing cash flow | $4.46M | $13.81M | -$4.76M | $18.68M | -67.7% |
| Share buybacks | — | $0 | -$260.00K | $0 | — |
| Financing cash flow | $30.43M | $164.00K | -$9.23M | -$1.22M | +18,453.0% |
| Free cash flow | -$22.79M | -$19.11M | -$21.83M | -$9.01M | -19.3% |
| End cash position | $30.28M | $18.09M | $23.22M | $59.11M | +67.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $2.75M | $2.99M | $1.54M | $1.30M | $4.08M | -8.1% |
| Selling, general & admin | $2.41M | $2.62M | $2.43M | $3.27M | $2.15M | -8.1% |
| Total operating expense | $5.16M | $5.61M | $3.96M | $4.58M | $6.23M | -8.1% |
| Operating income | -$5.16M | -$5.61M | -$3.96M | -$4.58M | -$6.23M | +8.1% |
| Net interest income | $509.00K | $309.00K | $303.00K | $235.00K | $122.00K | +64.7% |
| Pre-tax income | -$4.69M | -$5.31M | -$3.77M | -$4.23M | -$5.74M | +11.6% |
| Net income | -$4.69M | -$5.31M | -$3.77M | -$4.23M | -$5.74M | +11.6% |
| Net income to common | -$4.69M | -$5.31M | -$3.77M | -$4.23M | -$5.74M | +11.6% |
| Basic EPS | -0.04 | -0.06 | -0.04 | -0.06 | -0.16 | +33.3% |
| Diluted EPS | -0.04 | -0.06 | -0.04 | -0.06 | -0.16 | +33.3% |
| EBIT | -$5.16M | -$5.61M | -$3.96M | -$4.58M | -$6.23M | +8.1% |
| EBITDA | -$5.13M | -$5.59M | -$3.94M | -$4.55M | -$6.20M | +8.2% |
| Basic shares | 111.81M | 96.28M | 91.88M | 65.32M | 35.72M | +16.1% |
| Diluted shares | 111.81M | 96.28M | 91.88M | 65.32M | 35.72M | +16.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $57.16M | $61.32M | $30.28M | $33.12M | $11.49M | -6.8% |
| Cash & short-term investments | $57.16M | $61.32M | $30.28M | $33.12M | $11.49M | -6.8% |
| Total current assets | $57.98M | $62.27M | $31.04M | $33.58M | $11.95M | -6.9% |
| Property, plant & equipment | $663.00K | $781.00K | $822.00K | $927.00K | $447.00K | -15.1% |
| Total assets | $58.67M | $63.08M | $31.89M | $34.51M | $12.40M | -7.0% |
| Total current liabilities | $2.48M | $3.35M | $2.93M | $3.09M | $7.23M | -25.9% |
| Total debt | $584.00K | $692.00K | $719.00K | $745.00K | $259.00K | -15.6% |
| Total liabilities | $2.65M | $3.60M | $3.29M | $3.57M | $7.34M | -26.3% |
| Retained earnings | -$226.21M | -$221.52M | -$216.21M | -$212.43M | -$208.20M | -2.1% |
| Shareholder equity | $56.02M | $59.49M | $28.60M | $30.94M | $5.06M | -5.8% |
| Working capital | $55.50M | $58.93M | $28.10M | $30.48M | $4.72M | -5.8% |
| Net tangible assets | $56.02M | $59.49M | $28.60M | $30.94M | $5.06M | -5.8% |
| Shares issued | 63.41M | 63.23M | 61.46M | 60.68M | 35.72M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$4.69M | -$5.31M | -$3.77M | -$4.23M | -$5.74M | — | +11.6% |
| Depreciation & amortisation | $26.00K | $24.00K | $23.00K | $28.00K | $32.00K | — | +8.3% |
| Stock-based compensation | $1.09M | $930.00K | $737.00K | $401.00K | $563.00K | — | +17.0% |
| Change in working capital | -$574.00K | $49.00K | -$194.00K | -$4.52M | $2.50M | — | -1,271.4% |
| Operating cash flow | -$4.11M | -$4.30M | -$3.13M | -$8.43M | -$3.01M | — | +4.5% |
| Capital expenditure | -$71.00K | -$3.00K | -$44.00K | — | — | -$4.00K | -2,266.7% |
| Investing cash flow | -$71.00K | -$3.00K | -$32.00K | $0 | $0 | — | -2,266.7% |
| Financing cash flow | $42.00K | $35.35M | $283.00K | $30.07M | -$16.00K | — | -99.9% |
| Free cash flow | -$4.18M | -$4.30M | -$3.18M | -$8.43M | -$3.01M | — | +2.9% |
| End cash position | $57.16M | $61.32M | $30.28M | $33.12M | $11.49M | — | -6.8% |
Options analytics
Put / call volume
0.43
Call-heavy session
Put / call open interest
1.69
Positioning, not flow
Max pain
2.50
+78.6% from spot
ATM implied vol
243.8%
Nearest strike to spot
Skew (10% OTM)
+1,246.9%
Puts bid over calls
Call volume
7
Contracts, this expiry
Put volume
3
Contracts, this expiry
Heaviest call OI
2.50
246 contracts
Heaviest put OI
2.50
459 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.06 | -0.04 | +34.7% |
| Mar 2026 | -0.04 | -0.06 | -36.4% |
| Dec 2025 | -0.06 | -0.04 | +36.8% |
| Sep 2025 | -0.22 | -0.06 | +72.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.05 | 7 | $0 | 0.0% |
| Next quarter | -0.06 | 7 | $0 | 0.0% |
| Current year | -0.21 | 7 | $0 | 0.0% |
| Next year | -0.23 | 7 | $0 | 0.0% |
Analyst targets & ownership
Mean target$8.56
High target$20.00
Low target$4.00
Implied upside511.11%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy1 / 8
Hold0
Sell / Strong sell0 / 0
Held by insiders16.00%
Held by institutions65.76%
Institutions holding63
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.55
-9.91% from price
SMA 20
1.77
-21.06% from price
SMA 50
2.07
-32.41% from price
SMA 100
2.40
-41.58% from price
SMA 200
2.08
-32.67% from price
EMA 12
1.60
-12.33% from price
EMA 26
1.81
-22.67% from price
EMA 50
2.02
-30.67% from price
RSI (14)
26.5
Oversold
MACD (12,26,9)
-0.21
Hist -0.03
ATR (14)
0.13
9.06% of price
Realised vol 30D
79.0%
Annualised
Bollinger upper
2.31
20, 2σ
Bollinger lower
1.24
20, 2σ
50 / 200 cross
Death
2.07 vs 2.08
Trend bias
Below 200
-32.67%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.16
More volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
79.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-56.3%
Peak to trough
Max drawdown 5Y
-95.6%
Peak to trough
ATR 14
0.13
9.06% of price
Beta (reported)
1.92
5Y monthly, from filing
Short interest
Shares short
5.50M
Prior 5.53M
Change vs prior
-0.6%
Shorts covering
% of float
10.05%
Elevated
% of shares out
8.67%
Against total outstanding
Days to cover
13.9
Crowded exit
Float
36.97M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Piper Sandler | INITIATED | — | Overweight |
| Jun 2, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| May 28, 26 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| May 28, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| Apr 17, 26 | Roth Capital | MAINTAINED | Buy | Buy |
| Apr 16, 26 | B. Riley Securities | INITIATED | — | Buy |
| Apr 14, 26 | Raymond James | INITIATED | — | Strong Buy |
| Mar 13, 26 | Roth Capital | INITIATED | — | Buy |
| Mar 28, 25 | Leerink Partners | DOWNGRADE | Outperform | Market Perform |
| Nov 1, 24 | Jones Trading | DOWNGRADE | Buy | Hold |
| Aug 19, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-05
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-13
Proxy Statements
DEF 14A · 2026-04-15
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2026-04-14
Offering Registrations
S-3 · 2026-04-07
Proxy Statements
PRE 14A · 2026-03-30
Headlines
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
GlobeNewswire · 18h ago
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
GlobeNewswire · 2d ago
Equillium Announces Poster Presentations at the 7th International AHR Conference
GlobeNewswire · 8d ago
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
MarketBeat · 10d ago
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire · 21d ago
Equillium to Participate in Upcoming Investor Conferences
GlobeNewswire · 35d ago
EQ Inc. Reports Second Quarter 2026 Financial Results
ACCESS Newswire · 48d ago
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · 55d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.